AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
44.41
+1.11 (2.56%)
At close: Dec 5, 2025, 4:00 PM EST
44.35
-0.06 (-0.14%)
After-hours: Dec 5, 2025, 5:01 PM EST
AnaptysBio Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for AnaptysBio stock have an average target of 63.8, with a low estimate of 20 and a high estimate of 100. The average target predicts an increase of 43.66% from the current stock price of 44.41.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AnaptysBio stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $50 | Buy | Reiterates | $50 | +12.59% | Nov 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $52 → $51 | Strong Buy | Maintains | $52 → $51 | +14.84% | Nov 24, 2025 |
| Barclays | Barclays | Buy Maintains $83 → $70 | Buy | Maintains | $83 → $70 | +57.62% | Nov 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $59 → $52 | Strong Buy | Maintains | $59 → $52 | +17.09% | Nov 11, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $20 → $36 | Hold | Maintains | $20 → $36 | -18.94% | Nov 10, 2025 |
Financial Forecast
Revenue This Year
214.92M
from 91.28M
Increased by 135.45%
Revenue Next Year
136.34M
from 214.92M
Decreased by -36.56%
EPS This Year
-1.55
from -5.12
EPS Next Year
-4.30
from -1.55
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 242.1M | 212.4M | ||||
| Avg | 214.9M | 136.3M | ||||
| Low | 158.8M | 87.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 165.3% | -1.2% | ||||
| Avg | 135.5% | -36.6% | ||||
| Low | 73.9% | -59.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.51 | -1.17 | ||||
| Avg | -1.55 | -4.30 | ||||
| Low | -3.09 | -7.67 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.